Cite
HARVARD Citation
Cozijnsen, M. et al. (n.d.). Benefits and Risks of Combining Anti-tumor Necrosis Factor with Immunomodulator Therapy in Pediatric Inflammatory Bowel Disease. Inflammatory bowel diseases. 21 (4), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cozijnsen, M. et al. (n.d.). Benefits and Risks of Combining Anti-tumor Necrosis Factor with Immunomodulator Therapy in Pediatric Inflammatory Bowel Disease. Inflammatory bowel diseases. 21 (4), p. . [Online].